The Food and Drug Administration has given the green light to a new, lower-dose Covid-19 vaccine from Moderna. This vaccine is specifically for adults aged 65 and older, as well as those between 12 and 64 who have health conditions that put them at higher risk for severe Covid-19. It is important to note that this approval is limited to individuals who have already r...

The nation's vaccine landscape is undergoing significant changes. At the heart of these shifts is Robert F. Kennedy Jr. He has promised to work within the existing system. However, his team is hinting at major overhauls. The Food and Drug Administration (FDA) is preparing to roll out a new approach to vaccine testing and approval. This new framework is being led...

The FDA has given the green light to the Novavax COVID-19 vaccine. However, it comes with a catch. The vaccine is only for older adults and those over 12 with health issues that put them at high risk from COVID. This decision follows years of testing. The CDC has been discussing whether to limit COVID vaccines to only the most vulnerable. The FDA's move seems to ans...